MT-1 (Melanotan I)
Tanning peptide that darkens your skin by driving melanin production. An alpha-MSH analog with a cleaner side effect profile than MT-2.
MT-1 (Melanotan I): Tanning peptide that darkens your skin by driving melanin production. An alpha-MSH analog with a cleaner side effect profile than MT-2. MT-1 mimics a hormone your body uses to make pigment in your skin.
MT-1 mimics a hormone your body uses to make pigment in your skin. With sun or tanning-bed exposure, it gives you a darker tan from much less UV time. Cleaner side effect profile than the more popular MT-2.
Approved as Afamelanotide (Scenesse), 2019, for adults with erythropoietic protoporphyria.
Yes, Scenesse implant prescribed by dermatology / specialty providers for EPP. Off-label use for general pigmentation is outside the FDA approval.
Who it's for
- →Light-skinned users wanting baseline tan with less UV time
- →People who tried MT-2 and didn't tolerate the libido / nausea hit
- →Anyone running it under medical context (Afamelanotide is the drug version)
What to expect
- Week 1
Nausea at first doses. Slight darkening if UV exposure is paired.
- Week 4
Visible pigmentation if you've actually been in the sun.
- Week 8
Maintenance phase. Pigment holds with weekly dosing + occasional UV.
Looking at MT-1 (Melanotan I)? Your next 3 steps
- 1Work out your exact dose
Vial size + BAC water turns into the exact units to draw for MT-1 (Melanotan I).
Open calculator → - 2See what to stack & monitor
The companion supplements and the bloodwork worth tracking on this kind of protocol.
Bloodwork guide → - 3Save it & ask the Coach
A free account saves your stack; membership adds the stack-aware AI Coach.
Create free account →
How it works (mechanism)
Alpha-MSH analog that binds melanocortin receptors (primarily MC1R). MC1R activation in melanocytes triggers the eumelanin-production pathway, deepening skin pigment with UV exposure.
Dosing protocol
Stacks well with
Side effects
When NOT to use
- ⚠Personal history of melanoma
- ⚠Atypical mole syndrome
- ⚠Pregnancy / nursing
Common mistakes
- • Skipping the mole-map baseline
- • No UV exposure during the cycle (no pigment response)
- • Confusing dosing protocol with MT-2
Drug & supplement interactions
- ⚠MAO inhibitors theoretically amplify melanocortin response
- ⚠Antihypertensives: melanocortins may slightly elevate BP
- ⚠Use mole-mapping as monitoring; SSRIs may interact with mood-axis effects
The Pepdex take
Pepdex take: 500mcg loading for 14 days then 250mcg twice weekly is the standard pattern. Pigment holds cleanly with much less drama than MT-2, but the trade-off is real: tan ends up roughly 70% as deep as what MT-2 produces. MT-1 is the safer call though, no libido bump, no aggressive mole reactivity reports, no melanoma signal noise. If you want MT-2 results without the moles-and-libido conversation, this is the move. Take loading doses pre-bed to sleep through the nausea.
New to MT-1 (Melanotan I)? Grab the starter checklist.
Drop your email and we'll send the one-page first-cycle starter checklist, plus a heads-up if MT-1 (Melanotan I) changes legal status. No account needed.
No spam. No selling your email. Just the checklist and the occasional reclassification alert.
Ask the Coach anything about MT-1 (Melanotan I) or your own stack. This is it working.
Trained only on Pepdex content. Does the dose math, flags interactions, knows your stack. Won't push vendors, won't pretend to be a doctor.
Get the Coach, $7.99/mo →